Mahanta A, Chaulagain B, Trivedi R, Singh J
ACS Chem Neurosci. 2024; 15(21):4021-4032.
PMID: 39377785
PMC: 11870748.
DOI: 10.1021/acschemneuro.4c00392.
Madadi A, Sohn M
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204177
PMC: 11357388.
DOI: 10.3390/ph17081070.
Lamptey R, Sun C, Singh J
Mol Ther Nucleic Acids. 2024; 35(2):102210.
PMID: 38827383
PMC: 11141442.
DOI: 10.1016/j.omtn.2024.102210.
Zhang T, Yin H, Li Y, Yang H, Ge K, Zhang J
iScience. 2024; 27(6):109804.
PMID: 38770138
PMC: 11103379.
DOI: 10.1016/j.isci.2024.109804.
Surma M, Anbarasu K, Das A
Stem Cells. 2024; 42(7):607-622.
PMID: 38717908
PMC: 11228622.
DOI: 10.1093/stmcls/sxae033.
Non-Invasive Intranasal Delivery of : Effect of Multiple Dosing on the ApoE2 Expression in Mice Brain.
Gothwal A, Lamptey R, Trivedi R, Chaulagain B, Singh J
Int J Mol Sci. 2023; 24(16).
PMID: 37629200
PMC: 10456017.
DOI: 10.3390/ijms241613019.
Site-Specific knockdown of microglia in the locus coeruleus regulates hypervigilant responses to social stress in female rats.
Pate B, Bouknight S, Harrington E, Mott S, Augenblick L, Smiley C
Brain Behav Immun. 2023; 109:190-203.
PMID: 36682513
PMC: 11195023.
DOI: 10.1016/j.bbi.2023.01.011.
Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages.
Calero M, Moleiro L, Sayd A, Dorca Y, Miquel-Rio L, Paz V
Front Mol Biosci. 2022; 9:887678.
PMID: 36406277
PMC: 9671215.
DOI: 10.3389/fmolb.2022.887678.
Synthesis & Evaluation of Novel Mannosylated Neoglycolipids for Liposomal Delivery System Applications.
Mousavifar L, Lewicky J, Taponard A, Bagul R, Rivat M, Abdullayev S
Pharmaceutics. 2022; 14(11).
PMID: 36365120
PMC: 9692915.
DOI: 10.3390/pharmaceutics14112300.
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases.
Pandian S, Vijayakumar K, Murugesan S, Kunjiappan S
Heliyon. 2022; 8(6):e09575.
PMID: 35706935
PMC: 9189891.
DOI: 10.1016/j.heliyon.2022.e09575.
Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?.
Puris E, Fricker G, Gynther M
Pharm Res. 2022; 39(7):1415-1455.
PMID: 35359241
PMC: 9246765.
DOI: 10.1007/s11095-022-03241-x.
In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.
Arora S, Singh J
Int J Pharm. 2021; 608:121095.
PMID: 34543617
PMC: 8574129.
DOI: 10.1016/j.ijpharm.2021.121095.
Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes.
Lewicky J, Fraleigh N, Martel A, Nguyen T, Schiller P, Mousavifar L
Int J Mol Sci. 2021; 22(15).
PMID: 34360762
PMC: 8348236.
DOI: 10.3390/ijms22157996.
Lipid-Based Nanocarriers for The Treatment of Glioblastoma.
Iturrioz-Rodriguez N, Bertorelli R, Ciofani G
Adv Nanobiomed Res. 2021; 1(2):2000054.
PMID: 33623931
PMC: 7116796.
DOI: 10.1002/anbr.202000054.
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.
Arora S, Layek B, Singh J
Mol Pharm. 2020; 18(2):714-725.
PMID: 32787268
PMC: 10292003.
DOI: 10.1021/acs.molpharmaceut.0c00461.
Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.
Tsurubuchi T, Shirakawa M, Kurosawa W, Matsumoto K, Ubagai R, Umishio H
Cells. 2020; 9(5).
PMID: 32455737
PMC: 7290312.
DOI: 10.3390/cells9051277.
Inhibition of the activity of HIV-1 protease through antibody binding and mutations probed by molecular dynamics simulations.
Badaya A, Sasidhar Y
Sci Rep. 2020; 10(1):5501.
PMID: 32218488
PMC: 7098958.
DOI: 10.1038/s41598-020-62423-y.
Maltodextrin modified liposomes for drug delivery through the blood-brain barrier.
Gurturk Z, Tezcaner A, Dalgic A, Korkmaz S, Keskin D
Medchemcomm. 2018; 8(6):1337-1345.
PMID: 30108846
PMC: 6071985.
DOI: 10.1039/c7md00045f.
Surface modification of PGP for a neutrophil-nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein.
Chen B, Luo M, Liang J, Zhang C, Gao C, Wang J
Acta Pharm Sin B. 2018; 8(1):64-73.
PMID: 29872623
PMC: 5985696.
DOI: 10.1016/j.apsb.2017.11.012.
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
Patel M, Patel B
CNS Drugs. 2017; 31(2):109-133.
PMID: 28101766
DOI: 10.1007/s40263-016-0405-9.